Program Committee

Ángel Alberich-Bayarri, Ph.D.

Co-Founder and CEO

Quibim

William Audeh, M.D., M.S.

Chief Medical Officer

Agendia, Inc.

Lourdes Barrera, Ph.D.

Executive Director, Global Medical Affairs Oncology - Precision Medicine

Merck

Brian Caveney, M.D.

EVP & President, Early Development Research Laboratories & Chief Medical and Scientific Officer

Labcorp

Guillaume Cettou

Executive Director, Diagnostics

GSK

Okan Ekinci, M.D., MBA

Global Head of Digital Technology and Chief Medical Information Officer

Roche Information Solutions

Andrea Ferris

President and Chief Executive Officer

LUNGevity Foundation

Megan P. Hall, Ph.D.

Vice President of Medical & Corporate Affairs, and Distinguished Scientist

Grail

Lindsay Houff, MPP

Director Public Affairs

Guardant Health

Peter J. Hulick, M.D., MMSc, FACMG

Chair of Personalized Medicine

Endeavor Health

Tricia Kenny, MPhil, BS

Director, Enterprise Collaborations

Thermo Fisher Scientific

Richard Knight, MBA

Past President

American Association of Kidney Patients

James W. Lillard, Ph.D.

Senior Associate Dean

Morehouse School of Medicine

Nikki Martin

Senior Director, Precision Medicine Initiatives

LUNGevity Foundation

Howard McLeod, Pharm.D.

John Millholland, Ph.D.

Director, Diagnostic Sciences

BMS

Alasdair Milton, Ph.D.

Partner / Principal

KPMG, Healthcare & Life Sciences

Sharon Moulis, Ph.D.

Head of Companion Diagnostics and Clinical Assays

Pfizer

Lincoln Nadauld, M.D., Ph.D.

Chief Data Officer

Valinor

Omar Perez, Ph.D.

Head of Medical Diagnostics, US Medical Affairs Oncology

AstraZeneca

Sandy Prucka

Senior Director – Global Diagnostics Environment

Eli Lilly

Apostolia M. Tsimberidou, M.D., Ph.D.

Professor, Department of Investigational Therapeutics

The University of Texas MD Anderson Cancer Center

Sheila Walcoff

Founder & CEO

Goldbug Strategies, LLC

Reid Wilkening, M.D., Ph.D.

Field Medical Director

Karius

Michael Ybarra, M.D.

Chief Medical Officer

PhRMA